About Andhra Medi Pharma
Andhra Medi Pharma is an Agriculture company. Manufacturing of Active Pharmaceutical Ingredients, Bulk Intermediates, and Nutraceuticals from agricultural byproducts in India. It operates in the Agriculture and Healthcare sectors. The company has 89 employees. Its Indian entity Andhra Medi Pharma India Private Limited reported revenue of ₹76.02 Cr. Andhra Medi Pharma offers products and services including Chitin and Glucosamine. Its focus areas include Food and Agriculture, Bio-based Products, Shell Processing and Industrial Supplies.
Company details
Andhra Medi Pharma is recognized as a manufacturer that specializes in the production of Chitin, Chitosan, and Glucosamine from shrimp shells, which are supplied for use in agriculture, medicine, and cosmetics. The company has been established for over a decade, serving global markets across five continents and holding certifications like ISO 22000:2005 and HACCP. With a monthly production capacity exceeding 200 metric tonnes, products are exported to the E.U. and other regions, supported by facilities in India and a marketing office in Spain. Quality standards are maintained through various accreditations, ensuring compliance in international shipments.
- Employees 89
- SectorsAgricultureHealthcare
- Legal Name Andhra Medi Pharma India Pvt. Ltd
- Date of Incorporation 26 Nov, 2009
- Jurisdiction Vijayawada, Andhra Pradesh, India
- Indian entity revenue₹76.02 Cr
FY 2025 · +26% YoY
- Indian entity net profit₹1.23 Cr
FY 2025 · 2% margin
- Indian entity EBITDA₹4.52 Cr
FY 2025 · 6% margin
- Employee Count89
Associated legal entities of Andhra Medi Pharma
Andhra Medi Pharma operates through Andhra Medi Pharma India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Andhra Medi Pharma India Private Limited CIN U24233AP2009PTC065969 | Active | 26 Nov 2009 | Vijayawada, Andhra Pradesh | ₹76.0 Cr | 89 | 6 | View details |
Products & Services of Andhra Medi Pharma
Andhra Medi Pharma offers a comprehensive portfolio of products and services, including Chitin and Glucosamine.
Chitin is derived from shrimp shells and is utilized as a base material for Glucosamine-based products in various industries.
Glucosamine and its salts are manufactured for applications in medicine, cosmetics, and agriculture from processed shrimp shells.
Board of directors of Andhra Medi Pharma India Private Limited (Andhra Medi Pharma)
Andhra Medi Pharma India Private Limited is the primary company behind Andhra Medi Pharma. The board of Andhra Medi Pharma India Private Limited currently have 6 directors; the longest-serving is Anjana Chilakapati, appointed in 2009. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anjana Chilakapati DIN 01924734 | Director | 26 Nov 2009 | 16 yrs 10 mo | Andhra Medi Pharma India Private Limited |
| Rajeev Chilakapati DIN 01924690 | Director | 26 Nov 2009 | 16 yrs 10 mo | Andhra Medi Pharma India Private Limited |
| Kolathur Srinarayanan DIN 03306787 | Director | 03 Dec 2010 | 15 yrs 10 mo | Andhra Medi Pharma India Private Limited |
| Burugupalli Srinivas DIN 03299494 | Director | 03 Dec 2010 | 15 yrs 10 mo | Andhra Medi Pharma India Private Limited |
| Garikipati Kishore Kumar DIN 03305008 | Director | 15 Apr 2011 | 15 yrs 6 mo | Andhra Medi Pharma India Private Limited |
| Sirigina Srinivasa Rao DIN 03434218 | Director | 15 Apr 2011 | 15 yrs 6 mo | Andhra Medi Pharma India Private Limited |
Financials of Andhra Medi Pharma
Figures of Andhra Medi Pharma India Private Limited, the primary company behind Andhra Medi Pharma, for FY 2025. Revenue was ₹76.02 Cr (+26% year on year). Net profit was ₹1.23 Cr (2% margin). EBITDA was ₹4.52 Cr (6% margin). Revenue has grown at a compounded annual rate of +2% over three years and +17% over five years.
- ₹76.02 CrRevenue · FY 2025 · +26% YoY
- ₹1.23 CrNet profit · 2% margin
- ₹4.52 CrEBITDA · 6% margin
- ₹2.25 CrPaid-up capital
- 89Employees (provident fund records)
- +2%Revenue CAGR, 3 years
- +17%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Andhra Medi Pharma India Private Limited are on its company page.
Detailed financial statements for Andhra Medi Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Andhra Medi Pharma
Andhra Medi Pharma has 89 employees.
The primary company behind Andhra Medi Pharma, Andhra Medi Pharma India Private Limited, reported revenue of ₹76.02 Cr for FY 2025, up 26% year on year.
Andhra Medi Pharma is recognized as a manufacturer that specializes in the production of Chitin, Chitosan, and Glucosamine from shrimp shells, which are supplied for use in agriculture, medicine, and cosmetics. The company has been established for over a decade, serving global markets across five continents and holding certifications like ISO 22000:2005 and HACCP. With a monthly production capacity exceeding 200 metric tonnes, products are exported to the E.U. and other regions, supported by facilities in India and a marketing office in Spain. Quality standards are maintained through various accreditations, ensuring compliance in international shipments.
Andhra Medi Pharma offers Chitin and Glucosamine.
Andhra Medi Pharma operates through Andhra Medi Pharma India Private Limited.
The legal entities of Andhra Medi Pharma currently have 6 directors, including Kolathur Srinarayanan, Burugupalli Srinivas, Garikipati Kishore Kumar and others.